The Best Companies Bare All  

Oleh:

Jacobs, Tom

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 22 no. 11 (Nov. 2004), page 1363-1364.
Topik: diversified companies; companies

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.3 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

There are many indicia of a shareholder friendly biopharmaceutical company, but one is crucial, the ease with which an investor can understand the drug development pipeline and its chance of producing future wealth. The traditional startegy for an investor intent on discovering such details was to comb annual and quarterly company reports. Yet with web development and design cheaper and better every day, it is a mystery why more company websites do not provide clearer key pipeline information upfront. At minimum, a satisfactory company website should identify drugs and indications, trial status, trial results, and any shared drug ownership. Without this information, it's impossible to understand market size, competition, chances of success, and investor share of the wealth, all of which help an investor balance investments and decide to buy or sell.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali